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Summary 
Lipomas are one of the most common mesenchymal 
neoplasms in humans. They are characterized by con- 
sistent cytogenetic aberrations involving chromo- 
some 12 in bands q14-15. Interestingly, this region is 
also the site of rearrangement for other mesenchy- 
mally derived tumors. This study demonstrates that 
HMGI-C, an architectural factor that functions in tran- 
scriptional regulation, has been disrupted by re- 
arrangement at the 12ql4-15 chromosomal breakpoint 
in lipomas. Chimeric transcripts were isolated from 
two lipomas in which HMGI-C DNA-binding domains 
(AT hook motifs) are fused to either a LIM or an acidic 
transactivation domain. These results, identifying a 
gene rearranged in a benign neoplastic process that 
does not proceed to a malignancy, suggest a role for 
HMGI-C in adipogenesis and mesenchyme differenti- 
ation. 
Introduction * 
Understanding various genes and pathways underlying 
development of multicellular organisms should provide in- 
sights into the molecular basis of the highly regulated pro- 
cesses of cellular proliferation and differentiation. In turn, 
genetic aberrations in control of cell growth lead to a va- 
riety of developmental abnormalities and, most promi- 
nently, cancer (Aaronson, 1991). To pursue identification 
of genes involved in these fundamental biological pro- 
cesses, the viable pygmy mutation (MacArthur, 1944) was 
investigated because it gives rise to mice of small stature 
owing to a disruption in overall growth and development 
of the mouse. An insertional transgenic mutant facilitated 
cloning of the locus (Xiang et al., 1990), and subsequently 
it was shown that expression of the HMGI-C gene was 
abrogated in three pygmy alleles (Zhou et al., submitted). 
*These authors contributed equally to this work. 
HMGI-C belongs to the high mobility group (HMG) family 
of DNA-binding proteins that are abundant, heteroge- 
neous, nonhistone components of chromatin (Grosschedl 
et al., 1994). HMG proteins are divided into three distinct 
families, the HMG boxcontaining HMGl/HMG2, the active 
chromatin-associated HMGl4/HMG17, and the HMGI 
proteins (Grosschedl et al., 1994). At present, the last fam- 
ily consists of two genes, HMGI(Y), which produces two 
proteins via alternative splicing (Friedmann et al., 1993), 
and HMGI-C (Pate1 et al., 1994). A prominent feature of 
HMGI proteins is the presence of DNA-binding domains 
that bind to the narrow minor groove of AT-rich DNA 
(Reeves and Nissen, 1990) and are therefore referred to 
as AT hooks. Recently, valuable insights have been 
gained into their mechanism and role in transcription 
(Thanos and Maniatis, 1992; Du et al., 1993). They have no 
transcriptional activity per se (Wolffe, 1994), but through 
protein-protein and protein-DNA interactions, they orga- 
nize the framework of the nucleoprotein-DNA transcrip- 
tional complex. This is attained by their ability to change 
the conformation of DNA, and these proteins are therefore 
termed architectural factors (Wolffe, 1994). In the well- 
studied case of HMGI(Y) and the interferon p promoter, 
HMGI(Y) stimulates binding of NF-KB and ATF2 to appro- 
priate sequences and alters the DNA structure that allows 
the two factors to interact with each other and presumably 
with the basal transcription machinery (Thanos and Ma- 
niatis, 1992; Du et al., 1993). 
A number of studies have revealed an association be- 
tween increased expression levels of HMGI proteins and 
transformation (Giancotti et al., 1987,1989). For example, 
in chemically, virally, or spontaneously derived tumors, 
appreciable expression of HMGI-C was found in contrast 
with no detectableexpression in normal tissuesor untrans- 
formed cells (Giancotti et al., 1989). A recent study has 
demonstrated a more direct role for HMGI-C in transforma- 
tion (Berlingieri et al., 1995). Cells infected with oncogenic 
retroviruses failed to exhibit various phenotypic markers 
of transformation if HMGI-C protein synthesis was specifi- 
cally inhibited. 
DNA probes adjacent to HMGI-C were mapped to 
mouse chromosome 10 in a region syntenic to the long 
arm of human chromosome 12, including and distal to 
band q13 (Justice et al., 1990). This genomic region is 
under intensive investigation because it is the location of 
consistent rearrangements in a number of neoplasms, 
mainly of mesenchymal origin (Schoenberg Fejzo et al., 
1995). Lipomas, tumors mainly composed of mature fat 
cells, are one of the most common mesenchymal neo- 
plasms that occur in humans (Sreekantaiah et al., 1991). 
Approximately 50% of lipomas are characterized by cyto- 
genetic rearrangements, and the predominant alteration is 
a presumably balanced translocation involving 12ql4-15 
with a large variety of chromosomal partners, including 1, 
2,3,4,5,6,7,10,11,13,15,17,21,andX(Sreekantaiahet 
al., 1991; Fletcheret al., 1993). Thisvariability in reciprocal 
translocations, along with duplications, inversions, and 
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Figure 1. Genomic Structure of the Human HMGI-C Gene 
(A) H403, H409, H5003, HlOOl, and H4002 are genomic lFlXll clones 
(see Experimental Procedures) that contain the five exons (El-E5) of 
the human HMGI-C gene. (B) Exons are denoted by boxes and introns 
by a line. Overlapping I clones were not obtained within intron 3, 
and this region is denoted with a broken line. Sequences encoding 
potential functional domains, AUG and UAG codons, are shown in the 
exons. The AT hook motifs of the DNA-binding domains are shown 
as stippled areas, and the closed region (in E5) encodes for the acidic 
domain of unknown function. The figure is not drawn to scale because 
of the large 5’ and 3’ untranslated regions. 
deletions of 12q14-15 in these tumors, strongly indicates 
a primary role of a gene on chromosome 12 in lipomas. 
Furthermore, thisgene may play a key role in normal differ- 
entiation of primitive mesenchyme as not only lipomas, 
but also uterine leiomyomas(smooth muscle tumors), lipo- 
leiomyomas (smooth muscle and adipose components), 
and pulmonary chondroid hamartomas (primitive mesen- 
thyme, smooth muscle, adipose, and mature cartilage 
components) are all clonal proliferations that are charac- 
terized by rearrangements of 12q14-15 (Schoenberg 
Fejzo et al., 1995). Interestingly, breakpoints in a lipoma, 
a pulmonary chondroid hamartoma and uterine leiomyo- 
mata, have been shown to map within a single yeast artifi- 
cial chromosome (YAC) (Schoenberg Fejzo et al., 1995). 
HMGI-C is an attractive candidate gene to be implicated 
in lipoma formation. First, it is required in transformation 
(Berlingieri et al., 1995) and is a transcriptional regulatory 
factor, as are many genes identified at translocation 
breakpoints in a variety of tumors (Rabbitts, 1994). Sec- 
ond, disruption of HMGI-C leads to mice of small stature 
that, most intriguingly, have disproportionately less body 
fat than normal littermates (Benson and Chada, 1994). 
Finally, mouse HMGI-C maps to a region syntenic to hu- 
man 12q14-15, which is the area most frequently re- 
arranged in lipomas (Mandahl et al., 1988). Therefore, the 
human homolog of the mouse HMGI-C gene was cloned 
and its possible role in lipomas investigated. 
Results 
Genomic Isolation and Characterization 
of the Human HMGI-C Gene 
To obtain genomic clones of HMGI-C, we subcloned DNA 
from yeast strains harboring YACs yWPR383 and 
yWPR384 into the LFIXII vector. Because there is exten- 
sive conservation (96%) between mouse and human 
HMGI-C homologs (Pate1 et al., 1994), mouse HMGI-C 
cDNA fragments encompassing all five exons were used 
as probes on X libraries and five clones were isolated (Fig- 
ure 1A). Restriction mapping of li clones followed by 
Southern blot analysis allowed identification of various 
DNA fragments containing cross-hybridizing sequences. 
These fragments were subcloned and nucleotide se- 
quence analysis confirmed published data (Pate1 et al., 
1994). The first three exons each contain a DNA-binding 
domain encoding the AT hook motif that is characteristic 
of the HMGI family (Reeves and Nissen, 1990), and exons 
4 and 5 encode the acidic domain of the molecule (Manfio- 
letti et al., 1991) (Figure 1 B). Notably, a large intron (>25 
kb) between exons 3 and 4 separates the DNA-binding 
domains from the remainder of the protein (Figure IB). 
Fluorescence In Situ Hybridization of k HMGI-C 
Exon Clones to Lipoma Metaphase Chromosomes 
1 clones from 5’ and 3’ ends of HMGI-C were used as 
probes for fluorescence in situ hybridization (FISH) to tu- 
mor metaphase chromosomes. In lipoma ST90-375, con- 
taining a t(12;15)(q15;q24) translocation, L clone H403, 
which contains the 5’end of the gene, gave a hybridization 
signal on the der(l2), thus mapping proximal to the 
breakpoint (Figure 2A). In contrast, X clone H4002, which 
contains a portion of the 3’end of the HMGI-C gene, gave 
a hybridization signal on the der(15) and therefore maps 
distal to the breakpoint (Figure 28). This result is consis- 
tent with a disruption of HMGI-C due to the t(12;15) in this 
lipoma. Two other lipomas with translocations in 12q15 
were studied, similarly. In ST93724, containing a t(3; 
12)(q29;q15), X clone H409 containing the 5’ end of 
HMGI-C hybridized to the der(l2), while the 3’ end clone 
H4002 hybridized to the der(3) (Figures 2C and 2D). In 
ST91-198, with a t(12;13)(ql4-22;q21-32), the 5’ clone 
H403 mapped on the der(l3), suggesting a position distal 
to the breakpoint (Figure 2E). However, from the 3’ end, 
no hybridization to either derivative chromosome was 
noted in 20 of 20 metaphases using k clone H4002, indicat- 
ing that this portion of HMGI-C is deleted (Figure 2F). 
Therefore, in this tumor, the translocation appears to be 
proximal to HMGI-C, with the 5’ end of the gene retained 
but the 3’ end deleted, suggesting that the acidic tail of 
HMGI-C does not contribute to lipoma pathogenesis. Re- 
gardless of the chromosomal mechanisms involved in the 
translocations observed in lipomas, which may include a 
complex rearrangment in ST91-198, HMGI-C is disrupted 
in three out of three lipomas analyzed. 
identification of Chimeric Transcripts 
The molecular structure of the HMGI-C transcripts in the 
lipomas was next investigated. Total RNA was isolated 
(Chirgwin et al., 1979) from primary cell cultures of ST90- 
375 t(l2;15) and ST93-724 t(3;12), and 3’ rapid amplifi- 
cation of cDNA ends (RACE) performed (Frohman et al., 
1988). The resulting products were analyzed, and DNA 
fragments of size 441 and 627 bp were obtained from RNA 
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samples isolated from STQO-375 and ST93-724, respec- 
tively (Figure 3). These two DNA fragments were purified, 
subcloned, and sequenced. In both cases, sequence anal- 
ysis revealed an in-frame fusion of novel sequences to 
HMGI-C. These sequences differed between the two li- 
pomas and immediately followed exon 3 of HMGI-C (Fig- 
ure 4). 
The presence and specificity of chimeric transcripts in 
the two lipomas were confirmed further by an independent 
reverse transcription polymerase chain reaction (RT- 
PCR). cDNA was prepared from lipoma RNA samples, but 
primers from the novel sequences, instead of oligo(dT), 
were used for the reverse transcription reaction so that 
only RNA transcripts spanning the translocation would re- 
sult in a PCR amplification product (Figure 5). Products 
of the predicted size were observed only when primers 
derived from the novel sequences were used to reverse 
transcribe RNA isolated from the corresponding cell lines. 
Figure 2. FISH Mapping of HMGI-C 1 Clones 
to Metaphase Chromosomes from Three Lipo- 
mas Reveals Rearrangement of HMGI-C in All 
Three Tumors 
The normal chromosome 12 homologs provide 
internal positive hybridization controls and are 
marked by yellow arrows in each metaphase, 
while derivative chromosomes are marked by 
red arrows. h clones H403 and H409 from the 
5’ end of HMGI-C were used as FISH probes 
to lipoma metaphase chromosomes from 
ST90-375 (A) and ST93-724 (C), respectively. 
Note hybridization on the normal chromosome 
12 and the der(l2), demonstrating that these 
clones map proximal to the breakpoint in both 
lipomas. In contrast, when H403 was hybrid- 
ized to lipoma metaphase chromosomes from 
ST91-198 (E), hybridization was observed on 
the der(13) showing a map position distal to 
the breakpoint in this tumor. H4002 from the 
3’ end of HMGI-C was used as a FISH probe 
to lipoma metaphase chromosomes from 
ST90-375(B)and ST93-724(D); note hybridiza- 
tion on the normal chromosome 12 and the 
der(15) or der(3), respectively, indicating that 
these clones map distal to the breakpoint in 
both lipomas. However, FISH with H4002 from 
the B’end of HMGI-C on ST91-196 (F) revealed 
hybridization on the normal chromosome 12 
only, suggesting this clone is deleted from ei- 
ther the der(12) or der(13) in this tumor. Meta- 
phase spreads were counterstained with DAPI. 
Lipoma karyotypes are these: ST90-375, 
46,XX,t(l2;15)(ql5;q24); ST93-724, 46,XY,t(3; 
12)(q29;q15); and ST91-196, 46,XX,t(12;13) 
(q14-22;q21-32). 
No products were seen in lipoma RNA from STQO-375 or 
ST93-724 when primers 724 or 375 were used, respec- 
tively. Finally, the chromosomal origin of the novel se- 
quences was determined using DNA prepared from a mono 
chromosomal rodent-human somatic cell hybrid panel. 
Specific primers were designed for the two novel se- 
quences obtained from the lipoma cDNAs. PCR per- 
formed on genomic DNA from the somatic cell hybrids 
demonstrated that the novel sequence fused to HMGI-C 
in ST93-724, with a t(3;12), was located on chromosome 
3 and the novel sequence from STQO-375, with a t(l2; 15) 
mapped to chromosome 15 (data not shown). 
Novel Sequences Encode for Transcriptional 
Regulatory Domains 
A detailed computer analysis of the novel sequences from 
the two amplified fusion transcripts demonstrated that they 
encode putative transcriptional regulatory domains. In- 
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Figure 3. RT-PCR Amplification of HMGI-C Chimeric Transcripts 
3’ RACE on RNA from lipomas ST9@375 (375) and ST93724 (724) 
yield 441 bp and 672 bp products, respectively. Reverse transcription 
was performed with an oligo(dT) primer linked to an adapter sequence 
and was followed by a nested PCR with sense primers from exon 1 
and spanning exons 1 and 2. DLD-1 is a colorectal adenocarcinoma 
cell line that expresses wild-type HMGI-C (data not shown), but under 
these conditions, the predicted 3.1 kb wild-type message was not am- 
plified. Products were analyzed on a 1.5% agarose gel. Lane M shows 
molecular size markers in kilobases. 
spection of the predicted protein sequence from ST93-724 
revealed the presence of two tandemly arrayed LIM do- 
mains (Sanchez-Garcia and Rabbitts, 1993) separated by 
the characteristic 8-10 amino acids (Figure 8A). These 
domains are 50-80 amino acid residue motifs that are rich 
in cysteine and histidine and were first identified in three 
proteins, LIN-11, Isl-l , and MECB (Way and Chalfie, 1988; 
Freyd et al., 1990; Karlsson et al., 1990). The domain is 
organized into two adjacent zinc fingers separated by a 
two residue linker (Feuerstein et al., 1994), and members 
of the LIM family of proteins may contain one or more 
LIM domains (Sanchez-Garcia et al., 1993). Many of the 
LIM-containing proteins are transcription factors (Sdn- 
chezQarcfa et al., 1993) and their activity is thought to 
be regulated by protein-protein interactions through the 
ability of LIM domains to dimerize (Feuerstein et al., 1994). 
Computer analysis of the novel sequence from ST90- 
375 did not reveal any significant homology with known 
sequences. Notably, the carboxy-terminal end of the pre- 
dicted protein is highly acidic (pl 4.8) and rich in serine 
and threonine residues (Figure 88). Such domains have 
been implicated in transcriptional activation and have 
been shown to stimulate transcription from remote as well 
as proximal positions (Mitchell and Tijan, 1989; Seipel et 
al., 1992). 
Therefore, the predicted domain organization of the 
wild-type HMGI-C and the fusion proteins can be schemati- 
cally depicted as shown in Figure 7. In both fusion proteins, 
the C-terminal domain of the wild-type HMGI-C, which 
does not activate transcription (Thanos and Maniatis, 
1992; X. Z. and K. C., unpublished data), is replaced by 
distinct, potential transcription regulation domains. These 
newly acquired functional domains in combination with 
the AT hooksof HMGI-C would give rise to unique proteins 
that may contribute to the pathobiology of lipomas. 
NMGI-C 
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Figure 4. Rearrangements of 12ql5 in Human Lipomas Disrupt the 
HMGIC Gene and Produce Chimeric Transcripts 
HMGI-C denotes the nucleotide and amino acid sequence of the wild- 
type gene, and the open box sequence corresponds to the end of 
HMGI-C exon 3. t(3;12) and t(12;15) refer to the nucleotide and pre- 
dicted amino acid sequences of the chimeric transcripts from the 
cloned cDNA products obtained by 3’ RACE on RNA isolated from 
primary cell cultures of ST93724 t(3;12) and ST90-375 t(12;15), re- 
spectively. Chr. 3 and chr. 15 refer to the novel sequences derived 
from chromosome 3 or 15 in t(3;12) and t(12;15) lipomas, respectively. 
Only the sequences immediately adjacent to the fusion sites are 
shown. 
Discussion 
In this study, chimeric transcripts were identified from two 
lipomas that resulted from fusion of the 5’ end of the 
HMGI-C gene to novel sequences derived from different 
chromosomes. Three DNA-binding domains containing 
the AT hook motifs of HMGI-C are linked in these tran- 
scripts to sequences encoding potential transcriptional 
regulatory domains. In the case of lipoma ST99-375, the 
novel domain is highly acidic and rich in serine and threo- 
nine residues, resembling the typical activation domains 
found in transcription factors. In lipoma ST93-724, the 
novel protein contains two LIM domains, motifs that pro- 
mote protein-protein interactions. 
HMGI-C, Chimeric Transcripts, and Lipomas 
The chromosomal region 12q14-15 is hypothesized to con- 
tain an important gene involved in lipomas because it is 
the most commonly rearranged site (Mandahl et al., 1988). 
Our study establishes that HMGI-C is the gene disrupted in 
lipomas with chromosome 12 rearrangements. The large 
intron (>25 kb) between exons 3 and 4 distinctly separates 
the DNA binding from the acidic domains of HMGI-C. This 
provides a substantial target for translocations so that the 
three AT hook motifs remain intact and confer the DNA 
binding specificity of HMGI-C to the fusion proteins. 
HMGI-C is a 109 amino acid residue protein (Pate1 et 
al., 1994) that consists of three DNA-binding domains (AT 
hooks) linked to the carboxy-terminal acidic domain that 
does not activate transcription (Thanos and Maniatis, 
1992; X. Z. and K. C., unpublished data). The two lipoma 
translocations result in a novel protein containing AT 
hooksof HMGI-C at the amino terminus fused to transcrip- 
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Figure 5. RT-PCR Using Primers Located on Either Side of the Fu- 
sion Site between HMGI-C and Novel Sequences 
RNA refers to the lipoma source of total RNA. Primer 375 is an oligonu- 
cleotide that iscomplementary to the novel sequence from thechimeric 
transcript of lipoma ST90-375 and is located 8 nt downstream of the 
fusion point. Primer 724 is a complementary oligonucleotide to the 
novel sequence from the chimeric transcript of lipoma ST93-724 and 
is located 425 nt downstream of the fusion point. Total RNA from both 
lipoma primary cell cultures was reverse transcribed using either 375 
or 724 primers and PCR amplified using HMGI-C sense primer (which 
spans exons 1 and 2) and the antisense primer used for reverse tran- 
scription. Expected product sizes are 160 bp from ST90-375 cDNA 
with 375 primer and 597 bp from ST93-724 cDNA with 724 primer. 
tional regulatory domains at the carboxyl end. The other 
reported example for an AT hook-containing gene impli- 
cated in tumorigenesis is MLL (Tkachuk et al., 1992; Gu 
et al., 1992). However, the presence of a putative second 
DNA-binding domain (Ma et al., 1993) derived from the 
MLL gene and retained in the fusion protein obscures the 
exact contribution of the AT hooks to tumor pathogenesis 
(Rabbitts, 1994). In these lipomas, theonly known HMGI-C 
functional domains retained in the fusion proteins are the 
AT hooks. These motifs would therefore be responsible 
for DNA binding specificity of the fusion proteins. Although 
it is possible that simple truncation of HMGI-C is sufficient 
to cause lipomas, a number of studies have determined 
that both domains of fusion proteins are necessary for 
transforming activity (de Th6 et al., 1991; Kamps et al., 
1991; Pendergast efal., 1991; Mayetal., 1993).Therefore, 
as proposed for other fusion proteins, the heterologous 
sequence in the lipoma fusion proteins would alter the 
biological activity of wild-type HMGI-C and lead to deregu- 
lation of downstream target genes. 
The above model readily explains how the fusion protein 
produced in lipoma ST90-375 may function. The novel 
sequence from chromosome 15 encodes for an acidic pep 
tide rich in serine and threonine residues. These features 
have been observed in a number of transcriptional activa- 
tion domains (Mitchell and Tijan, 1989), including the car- 
boxy-terminal domains of homeobox proteins (Hatano et 
al., 1991) and NF-~B(Schmitzand Baeuerle, 1991). Sothe 
acquisition of a transactivation domain by the DNA-binding 
domains of HMGI-C, which normally possesses a tran- 
scriptionally inactive acidic domain, can easily be recon- 
ciled with aberrant regulation of the HMGI-C target genes. 
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Figure 6. Novel Sequences Fused to the DNA-Binding Domains of 
HMGI-C Encode Transcriptional Regulatory Domains 
(A) Comparison of the novel chromosome 3 sequence from ST93-724 
with the LIM domain-containing proteins zyxin (Sadler et al., 1992), 
apterous (Ap) (Cohen et al., 1992), Lh2 (Xu et al., 1993), LIN-11 (Freyd 
et al., 1990), and RBTN-1 (McGuire et al., 1969). Amino acids that 
constitute the LIM domain consensus are shown in bold. The amino 
acid spacing between residues is indicated by an x. In addition to 
the totally conserved cysteine, histidine, and aspartic acid residues 
(Sadler et al., 1992), LIM domains are characterized by the presence 
of an aromatic residue adjacent to the first histidine and a leucine 
located carboxy-terminal to the central HxxCxxCxxC cluster, which 
are indicated by arrows. Each LIM domain is designated 1, 2, or 3 
depending on its position relative to the amino terminus. 
(B) The potential transactivation acidic domain encoded by the se- 
quence derived from chromosome 15 in ST90-375. Acidic residues 
are underlined and the amino acids serine and threonine are in bold. 
In the case of the t(3;12) in ST93-724, the fusion protein 
must operate by a different mechanism to deregulate the 
HMGI-C target genes. The novel sequence from chromo- 
some 3 encodes for two tandemly arranged LIM motifs. 
The LIM domain is conserved among highly diverged spe- 
HHGI-C 
1 
Figure 7. Structure and Domain Organization of HMGI-C and the Pre- 
dicted Fusion Proteins 
The vertical broken line shows the location of junction sites in the 
chimeric products. DNA-binding domains of HMGI-C (AT) are pre- 
served in the fusion proteins, but the carboxy-terminal domain (stip 
pled) is replaced by potential transcriptional regulatory domains. LIM, 
LIM domain; minuses, acidic domain; S,T, serinelthreonine-rich 
domain. 
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ties, and LIM proteins have been shown to have important 
developmental functions that include patterning (Cohen 
et al., 1992) cell fate decision (Freyd et al., 1990), and 
differentiation (Way and Chalfie, 1988). LIM domain pro- 
teins are capable of protein-protein interactions (Sadler 
et al., 1992) through dimerization mediated by the LIM 
domains (Feuerstein et al., 1994). Therefore, LIM-LIM in- 
teractions between the ST93724 fusion product and other 
nuclear proteins could recruit potential transcriptional reg- 
ulators to DNA sequences with a specificity dictated by the 
HMGI-C AT hook motifs. Deregulation of HMGI-C target 
genes would then contribute to lipoma development. It is 
interesting to note that the majority of nuclear proteins 
capable of interacting with LIM domains are known to func- 
tion as transcription factors. These include several LIM 
homeodomain proteins (Sanchez-Garcia et al., 1993 and 
references within) as well as basic helix-loop-helix proteins 
shPan-1 (German et al., 1992) and TALl (Valge-Archer et 
al., 1994). While overexpression of LIM proteins has been 
implicated in T cell lymphomas (reviewed by Sanchez- 
Garcfa and Rabbit&, 1993) here we have an example of 
a LIM domain occurring in a fusion product. 
A great heterogeneity in chromosomal partners translo- 
cated with 12q14-15 is found in karyotypicalty abnormal 
lipomas, indicating that a large number of sequences in 
the genome can be fused to HMGI-C. Our data demon- 
strate that novel sequences linked to HMGI-C in two lipo- 
mas encode for distinct domains. This suggests that a 
number of alternative domains can be placed downstream 
of the HMGI-C AT hooks and contribute to the pathobiol- 
ogy of lipomas. Interestingly, both novel sequences de- 
scribed in this study encode for transcriptional regulatory 
domains. Therefore, we speculate that the choice of novel 
sequences in chimeric transcripts in lipomas is not arbi- 
trary but does require the presence of regulatory transcrip- 
tional domains attached to the HMGI-C AT hooks. A similar 
situation has been observed in the 11 q23 acute leukemia% 
where the MLL gene is translocated with multiple chromo- 
somal partners that mostly encode different types of tran- 
scriptional regulatory domains (Prasad et al., 1994). This 
could be a general mechanism for tumors where nonran- 
dom rearrangements of a specific chromosomal region 
involve avarietyof partners. Chimeric transcription factors 
that promote tumorigenesis would be produced by juxta- 
posing DNA-binding domain(s) contributed by the consis- 
tently rearranged locus to distinct types of transcriptional 
regulatory domains. 
HMGI-C, Pygmy, and Adipogcnesis 
The above studies demonstrate that an altered HMGI-C 
protein is involved in the abnormal growth and develop- 
ment of fat cells resulting in lipomas. This leads to the 
possibility that HMGI-C may normally play a role in adipo- 
genesis, and analysis of the pygmy mouse strongly sub- 
stantiates this hypothesis. The mouse mutant pygmy was 
found to be a null mutation of HMGI-C due to deletions 
within the gene (Zhou et al., submitted). The obvious phe- 
notypic characteristic of the pygmy mouse is its small size, 
and the reduction in most tissues is commensurate with 
the overall decrease in weight of the mouse (40% of wild 
type). Interestingly, one tissue disproportionately reduced 
in weight is body fat. The fat index, a reliable indicator of 
total fat content relative to body weight (Rogers and Webb, 
1980) is approximately eight times lower in pygmy than 
in their wild-type littermates (Benson and Chada, 1994). 
The function of HMGI-C in adipogenesis could be related 
to its role in cells undergoing differentiation. It isexpressed 
in less differentiated cells, but no detectable levels are 
observed in their terminally differentiated counterparts 
(Vartainen et al., 1988; Giancotti et al., 1987). Therefore, 
lack of HMGI-C expression, as found in the pygmy mouse, 
could affect the differentiation of preadipocytes into ma- 
ture adipocytes, cells capable of lipid storage. This devel- 
opmental abnormality would lead to adecrease in fat depo- 
sition and the phenotype observed in the pygmy mouse. 
The role of HMGI-C in adipogenesis and metabolic disor- 
ders such as obesity is thus of considerable interest. 
HMGI Family in Benign Tumors 
of Mesenchymal Origin 
Of major importance is the frequent observation of chro- 
mosomal rearrangements in bands 12ql3-15 in a large 
group of benign solid tumors. Most prominently, these in- 
clude uterine leiomyomata (Nilbert and Heim, 1990) and 
pleomorphic adenomas of the salivary gland (Sandros et 
al., 1990). Rearrangements of 12q13-15 have also been 
reported in pulmonary chondroid hamartomas (Dal Cin et 
al., 1993) endometrial polyps (Vanni et al., 1993), epithe- 
lial breast tumors (Rohen et al., 1993), hemangiopericy- 
toma (Mandahl et al., 1993) chondromatous tumors (Man- 
dahl et al., 1989) diffuse astrocytomas (Jenkins et al., 
1989) parosteal lipoma (Bridge et al., 1995), and a giant 
cell tumor of the bone (Noguera et al., 1989). Many of 
these tumor types are of mesenchymal origin, and it has 
therefore been hypothesized that a single gene associated 
with growth and mesenchyme may be responsible for 
these multiple neoplasms (Schoenberg Fejzo et al., 1995). 
Several lines of evidence implicate HMGI-C as a strong 
candidate for such a gene at 12q14-15. First, physical 
mapping studies have shown chromosomal breakpoints 
for three of these benign tumors (lipoma, pulmonary chon- 
droid hamartoma, and uterine leiomyoma) to map within 
a single YAC (Schoenberg Fejzo et al., 1995). This study 
assigns HMGI-C to the translocation breakpoint in lipo- 
mas, and chromosomal breakpoints in five analyzed uter- 
ine leiomyomata, as well as in a pulmonary chondroid ha- 
martoma, have been found to reside within lo-100 kb 
of exon 1 of HMGI-C (M. S. F. et al., unpublished data). 
Second, the role of HMGI-C in growth control is apparent 
because its disruption in the pygmy mouse leads to aber- 
rant growth and development. Also, it has been shown in 
vitro that HMGI-C is required fortransformation (Berlingieri 
et al., 1995). Finally, preliminary studies reveal that ex- 
pression of HMGI-C during mouse embryogenesis is re- 
stricted mainly to the mesenchymal component of tissues 
and organs (K. Benson, Y. Hou, and K. C., unpublished 
data). Taken together, these data indicate that HMGI-C 
is highly likely to be the gene disturbed by 12q14-15 re- 
arrangements in a number of tumors of mesenchymal 
origin. 
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Intriguingly, lipomas and the heterogeneous group of 
other mesenchymal neoplasms are benign tumors that 
rarely, if ever, undergo malignant conversion (Nilbert and 
Heim, 1990; Sandros et al., 1990; Sreekantaiah et al., 
1991). Molecular analyses of these neoplasms may eluci- 
date factors of decisive importance that minimize the likeli- 
hood of malignant progression. Although speculative at 
this stage, certain functional properties of HMGI-C sug- 
gest this molecule as a candidate for such a factor in the 
stabilization of the benign tumor state. For example, as 
an architectural factor important for the organization of 
higher order chromatin structures (Saitoh and Laemmli, 
1994), HMGI-C may play a role in the maintenance of geno- 
mic stability, thus preventing or retarding conversion of 
benign tumors to malignant ones. Interestingly, lipomas 
and other benign mesenchymal tumors that are likely to 
involve HMGI-C are characterized generally by few cyto- 
genetic rearrangements as compared with the highlycom- 
plex karyotypes typical of malignant tumors with a high 
degree of genomic instability (Fletcher et al., 1990). An 
equally valid hypothesis is the function of HMGI-C as an 
accessory transcription factor that may activate expres- 
sion of tumor suppressor genes, inhibit transcription of 
genes involved in malignant transformation (Yuspa et al., 
1969), or both. In any case, the molecular analysis of hy- 
perproliferating adipocytes in lipomas and mesenchymally 
derived cells in other benign tumors will provide insight 
into multiple independent events that cooperate to initiate 
and promote benign tumorigenesis. 
Nonrandom involvement of 6~21-23 has also been ob- 
served in lipomas (Sreekantaiah et al., 1991), pulmonary 
chondroid hamartomas (Fletcher et al., 1992) and uterine 
leiomyomata (Nilbert and Heim, 1990). Interestingly, 
HMGI(Y), the other member of the HMGI protein family 
with a similar structure as HMGI-C that includes the three 
DNA-binding domains, has been localized to 6~21 (Fried- 
mann et al., 1993). This raises an intriguing possibility that 
HMGI(Y), a molecule closely related to, but distinct from 
HMGI-C, could also be associated with benign tumors of 
mesenchymal origin. 
We show that a disruption of the HMGI-C gene resulting 
in chimeric transcripts is a characteristic feature of lipo- 
mas. As adipocytes play a key role in lipid homeostasis 
and maintenance of energy balance in vertebrates, an un- 
derstanding of HMGI-C function in adipogenesis may lead 
to insights into obesity and other metabolic disorders. In 
addition, the obvious role of HMGI-C in normal growth 
demonstrated by the phenotype of the pygmy mouse and 
its localization at or adjacent to the translocation breakpoints 
in lipoma, uterine leiomyoma, and pulmonary chondroid 
hamartoma suggests its fundamental involvement in a va- 
riety of benign tumors. 
Experimental Procedures 
isolation of YACs at the Human Pygmy Locus 
Initially, conserved fragments ware isolated from DNA at the mouse 
pygmy locus (Xiang et al., 1990; K. Benson and K. C., unpublished 
data) and were used as probes on a normal human I genomic library 
(Sambrook et al., 1989). Cross-hybridizing clones were isolated, and 
relevant homologous fragments were subcloned and sequenced. Spe- 
cific oligonucleotide primers (sequence S-AGGGGACAACAAATGCC- 
CACAGG and 5’CGTCACCAGGGACAGTTTCACTTGG) were syn- 
thesized and used to screen a human total genomic YAC library by 
the PC&based method (Green and Olson, 1990). Four positive clones 
of Saccharomyces cerevisiae containing YACs yWPR383, yWPR384, 
yWPR385, and yWPR386 were isolated. 
Construction and Screening of Phage Llbrarles 
High molecular weight DNA was isolated from yeast strains harboring 
YACs yWPR363 and yWPR384 (Guthrie and Fink, 1991) and was 
partially digested with Sau3A. After partial fill in of the Sau3A site, 
DNA was subcloned at the partially filled Xhol site of the predigested 
lFlXll vector (Stratagene, La Jolla, CA) and packaged in vitro (GIGA- 
PACK II packaging extract; Stratagene). To select clones derived from 
the human YACs, 6066 plaques from each library were probed with 
total human genomic DNA, and hybridizing plaques were spotted 
on plates inoculated with SRB(PP) cells in a gridded array. After incu- 
bating the plates at 3Q°C for 12 hr, plaques were transferred onto 
DURALON (Stratagene) membranes. These grids were used for identi- 
fying I clones that contained human HMGI-C exons by probing with 
mouse HMGI-C cDNA (Zhou et al., submitted), using hybridization 
conditions as described for Southern blot analysis (D’Armiento et al., 
1992). Overlaps between contiguous clones and colinearity with the 
genome were confirmed by a combination of clone to clone and clone 
to genomic hybridizations (D’Armiento et al., 1992) along with restric- 
tion mapping. 
Identification and Chsracterlzatlon of Chlmeric Transcripts 
First-strand cDNA was synthesized in a 20 pl reaction using an an- 
chored oligo(dT) primer 5’-GCAATACGACTCACTATAG(T)13 and 
Superscript II RNase H reverse transcriptase (Bethesda Research 
Laboratories, Gaithersburg, MD) according to the protocol of the manu- 
facturer. Primers used in the first round of 3’ RACE (Frohman et al., 
1988) were an HMGI-C exon 1 sense primer, S’CTTCAGCCC- 
AGGGACAACC, and an antisense adapter primer, 5’-GCAATACGA- 
CTCACTATAG. First-strand cDNA (1 )rl) was combined with 25 pmol 
of sense primer in a 50 ~1 reaction mixture (60 mM Tris-SO. [pH 9.1 
at 25%]; 18 mM (NH&SOI; 2 mM MgSO,; each dNTP at 200 PM; 
2.5 U of Taq DNA polymerase [Bethesda Research Laboratories]), 
denatured for 2 min at 94% and subjected to five cycles of linear 
amplification (Rother, 1992) using the following conditions: 94% for 
30 s, 56OC for 20 s, 72OC for 1.5 min. Antisense primer (10 pmol) was 
then added, and 25 cycles of exponential amplification were performed 
(94% for 30 s, 56% for 30 s, 72% for 1.5 min). PCR (1 pl) was 
reamplified for 20 cycles with a nested HMGI-C sense primer spanning 
exons 1 and 2,5’-GGAAGCAGCAGCAAGAACC, as described above. 
Each reaction (5 pl) was analyzed on a 1.5% agarose gel. Reverse 
transcription for the detection of chimeric transcripts using novel se- 
quence-specific primers was performed as above, except primers 375 
(S-CTTCTITCTCTGCCGCATCG) for STQO-375 and 724 (5’-GTGAG- 
GATGATAGGCCTTCC) for ST93-724 were used. Subsequent PCR 
conditions were an initial denaturation at 94OC for 2 min and 30 cycles 
at 94°C for 30 s, 58% for 30 s, and 72OC for 1 min, followed by a 
final extension for 10 min at 72°C. 
Chimeric transcripts amplified by 3’ RACE and RT-PCR were iso- 
lated from the gel, blunt-end cloned by standard methods (Sambrook 
et al., 1989) into the pCR-Script vector (Stratagene). and sequenced 
using the Sequenase kit version 2.0 (United States Biochemicals, 
Cleveland, OH). 
Tumor Cell Lines and Chromosome Preparations 
Lipoma specimens were obtained from patients at the time of surgery. 
Tumor culture, metaphase chromosome harvesting, slide preparation, 
and trypsin-Giemsa banding were performed as described previously 
(Fletcher et al., 1991). Metaphases with rearrangements of chromo- 
some 12 in band q15 were identified, and corresponding cell pellets 
were stored in fixative at -20% were used to prepare slides for FISH. 
These slides were stored at room temperature for at least 10 days 
prior to hybridization. 
1 clones shown in Figure 1 were mapped to lipoma tumor metaphase 
chromosomes from STQO-375 [46,XX,t(12;15)(ql5;q24)], STQl-198 
[46,XX,t(l2;13)(ql4-22;q21-32)], and ST93-724 [46,XY,t(3;12)(q29; 
q15)]. Karyotypes for lipomas STQO-375 and STQI-198 have been re- 
ported previously (Fletcher et al., 1993). 
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FISH with I Clones 
Slides for FISH were prepared as recommended in the hybridization 
kit by Onwr (Gaithersburg, MD) except for denaturation at 88% for 
30 s. 5 probes were labeled with digoxigenin-11 dUTP (Boehringer 
Mannheim, Indianapolis, IN) using 1 pg of the appropriate 1, DNA using 
dNTPs obtained from Boehringer Mannheim and the DNase I-DNA 
polymerase I mix from the BioNick labeling system (Bethesda Rea- 
search Laboratories). Labeling reactions were performed at 18°C for 
2 hr. Digoxigenin-labeled probe (500 ng) was lyophilized with 5 pg of 
Cot-l DNA (Bethesda Research Laboratories) and resuspended in 20 
~1 deionized water. Resuspended probe (2 ~1) was added to 9 PI of 
Hybrisol VI (Oncor). The 5 probe was denatured, hybridized to slides, 
and washed according to standard protocols (Oncor). Digoxigenin- 
labeled 5 clones were detected using the fluorescein-labeled antidig- 
oxigenin antibody (Oncor) according to the recommendations of the 
manufacturer. Metaphase chromosomes were counterstained with 
4,8diamidino-2-phenylindole-dihydrochloride (DAPI) according to the 
protocol supplied by Oncor. Hybridization was observed using a Zeiss 
Axioskop microscope and images captured with the CytoVision Im- 
aging System (Applied Imaging). 
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